Peter Johannes Holst

Peter Johannes Holst

Guest Researcher

Member of:

  • EXPVACC/LEV team

ORCID: 0000-0002-1279-304X

Publication year:
All
1 - 4 out of 4Page size: 25
  1. 2010
  2. Published

    Adenoviral vaccination combined with CD40 stimulation and CTLA-4 blockage can lead to complete tumor regression in a murine melanoma model

    Sørensen, M. R., Holst, Peter Johannes, Steffensen, Maria Abildgaard, Christensen, Jan Pravsgaard & Thomsen, Allan Randrup, 24 Sep 2010, In: Vaccine. 28, 41, p. 6757-64 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    DNA fusion gene vaccines

    Holst, Peter Johannes, Bassi, Maria Rosaria, Thomsen, Allan Randrup & Christensen, Jan Pravsgaard, 2010, In: Current Opinion in Molecular Therapeutics. 12, 1, p. 47-54 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Quality of the transgene-specific CD8+ T cell response induced by adenoviral vector immunization is critically influenced by virus dose and route of vaccination

    Holst, Peter Johannes, Ørskov, Cathrine, Thomsen, Allan Randrup & Christensen, Jan Pravsgaard, 2010, In: Journal of Immunology. 184, 8, p. 4431-9 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    The murine gammaherpesvirus-68 chemokine-binding protein M3 inhibits experimental autoimmune encephalomyelitis

    Millward, J. M., Holst, Peter Johannes, Høgh-Petersen, M., Thomsen, Allan Randrup, Christensen, Jan Pravsgaard & Owens, T., 2010, In: Journal of Neuroimmunology. 224, 1-2, p. 45-50 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 7853